S
096530
vs
K
KOSPI 200
Over the past 12 months, Seegene Inc has underperformed KOSPI 200, delivering a return of -9% compared to the KOSPI 200's +105% growth.
Stocks Performance
096530 vs KOSPI 200
Performance Gap
096530 vs KOSPI 200
Performance By Year
096530 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Seegene Inc
Glance View
Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.
